A case of post-BCG therapy renal granuloma concurrent with ureteral carcinoma
Tatsuya Otaki1, Nobuyuki Nakajima1, Akira Miyajima2
1Department of Urology, Tokai University Oiso Hospital, Japan.
Abstract:
Intravesical administration of Bacillus Calmette-Guerin (BCG) is recommended to reduce the risk of recurrence or progression of carcinoma in situ, stage Ta tumors of high grade, or stage T1 tumors. Renal complications following intravesical BCG therapy are rare. The mechanism of renal granuloma formation may be related to vesicoureteral reflux. Vesicoureteral reflux after transurethral resection of bladder tumors (TURBT) has been reported to be higher when the tumor is located near the ureteral orifice. Herein, we report a case of a renal granuloma after BCG therapy with concurrent ipsilateral urethral carcinoma.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
03:19Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
Published on: June 21, 2024
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Imaging Studies III: Computed Tomography
Kidney Transplant III: Nursing Management
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
